Safety Alert: Placentyne Hair Lotion Has Been Banned, NAFDAC Warns Nigeria

0

CEM REPORT | The National Agency for Food and Drug Administration and Control (NAFDAC) has warned all Nigerian against the use of a cosmetic product, Placentyne Hair Lotion.

NAFDAC said it received safety information from the European Rapid Alert System for dangerous non-food products (RAPEX) that the product has been banned.

This is according to a public alert with No. 0033/2022, and titled, ‘European Rapid Alert System for Dangerous Non-Food Products (RAPEX) Banned Cosmetic Product, Placentyne Hair Lotion’, issued by the management of the agency.

The agency according to the alert noted that the product contain a mixture of preservatives Methylchloroisothiazolinone and Methylisothiazolinone (MCI and MI) which are forbidden in leave-on cosmetics having been linked to lung toxicity, allergic reactions and possible neurotoxicity..

‘’The product is sold in a 12 ampoules x 10ml cardboard box manufactured by an Italian company, Linea Italiana di Benazzi Anna & SAS with a barcode No. 8029550000126.

‘’Methylchloroisothiazolinone and Methylisothiazolinone (MCI and MI) are common preservatives which are found in many liquids personal care products, which have been linked to lung toxicity, allergic reactions and possible neurotoxicity.

“Both chemicals inhibit bacterial growth in cosmetic products on their own, but they are most commonly used as a mixture in products.

NAFDAC hence urged importers, distributors, retailers, healthcare providers and consumers to stop importation, distribution, sale and use of the product while also appealing to members of the public to discontinue use and handover stock to the nearest NAFDAC office.

“NAFDAC implores importers, distributors, retailers, healthcare providers and consumers to immediately stop importation, distribution, sale and use of Placentyne Hair Lotion 12ampoules x 10ml by Linea Italiana di Benazzi Anna & SAS

“Members of the public in possession of the recalled lots of the product are implored to discontinue sale or use and handover stock to the nearest NAFDAC office.

[READ ALSO] World Bank Warns CBN on Policies That Will Harm Commercial Banks

The agency further urged report of adverse effect of the product via it toll free lines or email.

“NAFDAC encourages healthcare professionals, consumers and patients to report adverse events related to the use of this product to the nearest NAFDAC office, or NAFDAC PRASCOR (20543 TOLLS FREE from all networks), also via pharmacovigilance@nafdac.gov.ng or via the NAFDAC ADR e-Reporting platform available at www.nafdac.gov.ng.”

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments